Background {#sec1_1}
==========

An accessory spleen is not rare and is observed in 10% of patients at necropsy \[[@B1]\], and 17% of accessory spleens are located within the pancreatic tail \[[@B2]\]. However, an epithelial cyst in an intrapancreatic accessory spleen (ECIAS) is rare. It is very difficult to diagnose preoperatively using conventional imaging such as ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI). Therefore, ECIAS is commonly misdiagnosed as other cystic neoplasms, and patients undergo surgical resection. Laparoscopic distal pancreatectomy (Lap-DP) is a safe and minimally invasive procedure and has recently been accepted for benign or low-grade malignant tumors located in the distal pancreas.

We herein report a case of a patient with ECIAS who underwent laparoscopic spleen-preserving distal pancreatectomy (Lap-SPDP) and include bibliographical comments.

Case Presentation {#sec1_2}
=================

A 57-year-old woman was referred to our hospital because a pancreatic tail tumor had been detected during a health examination. She was asymptomatic, and a physical examination revealed no remarkable abnormalities. A laboratory examination showed normal findings. The levels of the tumor marker carbohydrate antigen 19-9 (CA19-9) and s-pancreas-1 antigen (SPan-1) were elevated to 439 U/mL (normal range, \<37 U/mL) and 160 U/mL (normal range, \<30 U/mL), respectively. US showed a well-defined homogeneous cystic tumor (Fig. [1a](#F1){ref-type="fig"}). CT showed a well-demarcated cystic tumor measuring 2.2 cm in size in the pancreatic tail (Fig. [1b](#F1){ref-type="fig"}). MRI showed that the cystic tumor exhibited low intensity on T1-weighted images and high intensity on T2-weighted images (Fig. [1c, d](#F1){ref-type="fig"}). Based on these preoperative examination findings, the pancreatic tumor was diagnosed as mucinous cystic neoplasm.

The patient underwent Lap-SPDP. Under general anesthesia, the patient was placed in the right semilateral position. Three trocars were placed: (1) at the middle umbilical site for laparoscopy (12 mm), (2) at the epigastric margin as a working trocar (5 mm), and (3) at the left lateral abdomen on the anterior axillary line as a working trocar (12 mm) (Fig. [2a](#F2){ref-type="fig"}). Laparoscopic US was performed to confirm the location of the tumor and to determine the resection line of the pancreas. Dissection was performed within the avascular plane along the posterior surface of the pancreas from the inferior border. Many branches of the splenic vessels were divided from the pancreatic body toward the tail using a vessel-sealing device, and the distal pancreas was mobilized (Fig. [2b](#F2){ref-type="fig"}). The pancreatic parenchyma was transected with an endoscopic linear stapler. After enlarging the middle umbilical site port, the specimen was removed from the abdominal cavity via an endoscopic bag retrieval system. A closed drain was placed at the stump of the pancreas. The operative time was 144 min, and the intraoperative blood loss was 10 mL.

The resected specimen showed a well-demarcated cystic lesion surrounded with spleen-like tissue (Fig. [3a](#F3){ref-type="fig"}). A histopathological examination revealed the cyst wall to be lined by stratified squamous epithelium within splenic parenchyma (Fig. [3b](#F3){ref-type="fig"}). Based on these pathologic findings, the ultimate diagnosis was ECIAS. The postoperative course was uneventful, and the patient was discharged on postoperative day 12. Serum CA19-9 and SPan-1 levels returned to the normal range postoperatively.

Discussion {#sec1_3}
==========

An accessory spleen is congenitally duplicated splenic tissue that is separated from the main body of the spleen and is observed in 10% of patients at necropsy \[[@B1]\]. The splenic hilum is the most common site of the accessory spleen, and 17% of accessory spleens are located within the pancreatic tail \[[@B2]\]. ECIAS is rare and was first described by Davidson et al. \[[@B3]\] in 1980. Kato et al. \[[@B4]\] summarized their experience with 39 cases of ECIAS in 2016. These cases involved 15 males and 24 females, and the median age was 48 years. All cystic tumors were located in the pancreatic tail. The cystic tumor appeared to be unilocular in 12 cases and multilocular in 21 cases. The average cystic tumor size was 4.5 cm. Wakasugi et al. \[[@B5]\] reported that preoperative serum CA19-9 levels were elevated in 31% of cases.

ECIAS has no malignant potential, so surgical resection for the ECIAS may not be necessary. However, all of these patients underwent surgical resection because the possibility of malignant cystic tumors could not be ruled out. Therefore, an accurate preoperative diagnosis for cystic tumor of the pancreas is important. On US, the solid component of the ECIAS shows the same echogenicity as the spleen. On CT, the cystic wall of the ECIAS shows contrast enhancement similar to that of the spleen during multiphasic scans. On MRI, the solid component of the ECIAS shows the same intensity as that of the spleen, and cystic lesions commonly show low intensity on T1-weighted images and high intensity on T2-weighted images. Few previously reported cases were correctly diagnosed using conventional imaging \[[@B6], [@B7]\]. In particular, when the amount of accessory splenic tissue is small, accurate preoperative diagnosis by image findings is very difficult. In our case, ECIAS was diagnosed as mucinous cystic neoplasm preoperatively because the amount of accessory splenic tissue was small. An endoscopic US-guided fine needle aspiration (EUS-FNA) biopsy for the differential diagnosis of ECIAS was performed for 4 reported cases \[[@B4]\]. However, a correct pathological diagnosis was not achieved in any of the 4 reported cases, because the amount of solid component was too small to be successfully biopsied by EUS-FNA. In our case, EUS-FNA was not performed for the diagnosis of pancreatic cystic tumor. Therefore, the preoperative diagnosis of the ECIAS is very difficult at present. However, ECIAS should be considered in the differential diagnosis of pancreatic tail cystic tumors.

When it is difficult to diagnose an intrapancreatic cystic tumor, as in our case, and a malignant tumor cannot be completely ruled out, laparoscopic surgery is the better way to avoid the drawbacks of open surgery, such as increased pain and prolonged hospitalization. Lap-DP has recently been accepted for benign or low-grade malignant tumors located in the distal pancreas. There are only 12 reported cases including our own of ECIAS treated by laparoscopic surgery in the English literature (Table [1](#T1){ref-type="table"}) \[[@B4], [@B5], [@B6], [@B7], [@B8], [@B9], [@B10], [@B11], [@B12], [@B13]\]. In these cases, the median age of the patients was 50 years (range, 21--67 years) and included 3 males and 9 females. The median tumor size was 2.8 cm (range, 1.5--5 cm). The median operative time was 204 min (range, 140--278 min), and the median blood loss was 50 mL (range, 10--400 mL). The median postoperative hospital stay was 12 days (range, 3--21 days). In our case, it was thought that laparoscopic surgery was a safe and minimally invasive procedure for the patient because there was a short operative time, little blood loss, and no postoperative complication. Lap-DP and Lap-SPDP have been performed in 6 patients each. We performed Lap-SPDP because the immunological role of the spleen has been increasingly emphasized and the preservation of the spleen is preferable to avoid long-term complications associated with splenectomy \[[@B14]\].

Conclusions {#sec1_4}
===========

ECIAS is rare and very difficult to accurately diagnose preoperatively. Laparoscopic surgery is a safe and minimally invasive procedure for patients with difficult-to-diagnose pancreatic tail tumor suspected of having low-grade malignancy.
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![**a** Ultrasonography showed a well-defined homogeneous cystic tumor (arrow). **b** Contrast-enhanced computed tomography showed a well-demarcated cystic tumor measuring 2.2 cm in size in the pancreatic tail (arrow). **c**, **d** Magnetic resonance imaging showed that the cystic tumor exhibited low intensity on T1-weighted images (**c**; arrow) and high intensity on T2-weighted images (**d**; arrow).](crg-0011-0803-g01){#F1}

![**a** Port placement. **b** Intraoperative findings.](crg-0011-0803-g02){#F2}

![**a** The resected specimen showed a well-demarcated cystic lesion surrounded by spleen-like tissue. **b** A histopathological examination revealed the cyst wall to be lined by stratified squamous epithelium within splenic parenchyma. Hematoxylin-eosin staining. ×40.](crg-0011-0803-g03){#F3}

###### 

Reported laparoscopic surgical cases of an epithelial cyst in an intrapancreatic accessory spleen

  No.   First author \[Ref.\], year        Age, years   Sex   Symptom                 Location   Size, cm   Form of cyst   Preoperative serum CA19-9   Postoperative serum CA19-9   Preoperative diagnosis   Surgical procedure   Operative time, min   Intra-operative blood loss, mL   Postoperative complications   Postoperative hospital stay, days
  ----- ---------------------------------- ------------ ----- ----------------------- ---------- ---------- -------------- --------------------------- ---------------------------- ------------------------ -------------------- --------------------- -------------------------------- ----------------------------- -----------------------------------
  1     Itano \[[@B6]\], 2010              67           M     Epigastric pain         Tail       1.5        Uni            182 U/mL                    ND                           ECIAS                    Lap-DP               227                   400                              None                          7
                                                                                                                                                                                                                                                                                                                       
  2     Iwasaki \[[@B8]\], 2011            36           F     Left hypochondalgia     Tail       3.4        Multi          79 U/mL                     NR                           MCN                      Lap-DP               180                   30                               None                          12
                                                                                                                                                                                                                                                                                                                       
  3     Khashab \[[@B9]\], 2011            49           F     Abdominal pain          Tail       2.3        ND             ND                          ND                           NET                      Lap-SPDP             ND                    ND                               ND                            ND
                                                                                                                                                                                                                                                                                                                       
  4     Urakami \[[@B7]\], 2011            50           F     Asymptomatic            Tail       3          Uni            ND                          ND                           ECIAS                    Lap-SPDP             246                   Minimal                          None                          10
                                                                                                                                                                                                                                                                                                                       
  5     Panagiotopoulos \[[@B10]\], 2012   51           M     Asymptomatic            Tail       2          ND             ND                          ND                           Malignant cystic tumor   Lap-SPDP             ND                    ND                               None                          3
                                                                                                                                                                                                                                                                                                                       
  6     Harris \[[@B11]\], 2012            39           M     Asymptomatic            Tail       2.5        ND             ND                          ND                           Malignant cystic tumor   Lap-DP               140                   250                              None                          8
                                                                                                                                                                                                                                                                                                                       
  7     Wakasugi \[[@B5]\], 2013           37           F     Asymptomatic            Tail       4          Multi          251 U/mL                    NR                           MCN, IPMN                Lap-DP               278                   50                               PF (grade A)                  21
                                                                                                                                                                                                                                                                                                                       
  8     Kwak \[[@B12]\], 2016              21           F     Abdominal pain, fever   Tail       2.5        Multi          NR                          ND                           SPN                      Lap-DP               ND                    ND                               ND                            ND
                                                                                                                                                                                                                                                                                                                       
  9     Kato \[[@B4]\], 2016               33           F     Asymptomatic            Tail       3          Multi          NR                          ND                           SPN, NET                 Lap-SPDP             ND                    ND                               ND                            ND
                                                                                                                                                                                                                                                                                                                       
  10    Fujii \[[@B13]\], 2016             50           F     Asymptomatic            Tail       5          Uni            43.1 U/mL                   NR                           MCN                      Lap-SPDP             ND                    ND                               None                          14
                                                                                                                                                                                                                                                                                                                       
  11    Fujii \[[@B13]\], 2016             60           F     Back discomfort         Tail       3.5        Multi          52.9 U/mL                   NR                           IPMN                     Lap-DP               ND                    ND                               None                          14
                                                                                                                                                                                                                                                                                                                       
  12    Our case, 2017                     57           F     Asymptomatic            Tail       2.2        Uni            439 U/mL                    23 U/mL                      MCN                      Lap-SPDP             144                   10                               None                          12

ND, not described; NR, normal range; Uni, unilocular; Multi, multilocular; ECIAS, epithelial cyst in an intrapancreatic accessory spleen; MCN, mucinous cystic neoplasm; NET, neuroendocrine tumor; IPMN, intraductal papillary mucinous neoplasm; SPN, solid pseudopapillary neoplasm; Lap-DP, laparoscopic distal pancreatectomy; Lap-SPDP, laparoscopic spleen-preserving distal pancreatectomy; PF, pancreatic fistula.
